Drilling off to a cracking start at Manitouwadge

|

Published 26-NOV-2015 08:33 A.M.

|

1 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Drilling at Ardiden’s (ASX:ADV) graphite project in Canada is off to a good start with 14 out of 15 holes hitting mineralisation and testing confirming low-cost floatation was a good fit for its graphite.

It has been drilling at its Manitouwadge graphite project in Canada since the start of the month, testing the Silver Star and Silver Birch electromagnetic anomalies.

The effective strike length of these anomalies is 19.3km and previous sampling had confirmed graphite flake size distribution of jumbo and large flake graphite in up to 80% of samples.

ADV told its shareholders yesterday that it had managed to drill 15 diamond holes for 1216m, with 14 out of 15 hitting mineralisation.

Samples from the drilling have been sent off from the lab for assessment.

It also told its shareholders that further metallurgical work on the previous sampling had confirmed low-cost floatation beneficiation could bring its graphite up to 96.8% total graphitic content.

This was an improvement on previous tests which had finished with a grade of 95.6%.

The feed grade for the latest testing was 11.4%.

It said the positive result meant that it could now start to think about whether to sell the raw product, or process it further to achieve grades of up to 99.5%.

More on the Manitouwadge project

Previous diamond drilling at the project identified surface graphite at depth, with grades comparable to that of other deposits in Ontario including that of TSX-listed companies such as Zenyatta Ventures and Northern Graphite, both of which have seen excellent results in preliminary economic assessments.

Manitouwadge is just 100km from Zenyatta Ventures Ltd’s Albany deposit which is also on the edge of the Quetico sub-province.

tags

GRAPHITE


General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X